1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine,
dextofisopam,
EGYT-341,
Grandaxin,
levotofisopam,
tofisopam,
tofizopam,
tofisopam,
22345-47-7,
Grandaxin,
tofizopam,
Seriel,
Egyt 341,
Tofisopamum,
1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine,
Tofisopamum [INN-Latin],
Tofisopam [INN:DCF:JAN],
EINECS 244-922-3,
RUJBDQSFYCKFAA-UHFFFAOYSA-N,
5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-,
1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-benzo[d][1,2]diazepine,
NCGC00165912-02,
Q-201839,
Emandaxin,
7,8-Dimethoxy-1-(3,4-dimethoxyphenyl)-5-ethyl-4-methyl-5H-2,3-benzodiazepine,
CCRIS 8738,
Emandaxin (TN),
AC1L1KHG,
DSSTox_CID_3681,
Tofisopam (JP17/INN),
DSSTox_RID_77145,
DSSTox_GSID_23681,
SCHEMBL43522,
Tofisopam (patented in japan),
CHEMBL404216,
EGYT-341,
SCHEMBL8086894,
DTXSID3023681,
CHEBI:32241,
CTK4E9226,
BCP09600,
Tox21_112269,
MFCD00823171,
Tofisopam, >=98% (HPLC), solid,
AKOS025401672,
DB08811,
QC-1212,
ACM22345477,
NCGC00165912-01,
AC-24288,
BC657206,
CC-35086,
LS-34080,
SC-20295,
CAS-22345-47-7,
FT-0638212,
X6663,
D01254,
345T477,
C-31755,
BRD-A69095630-001-01-1,
1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine,
1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy- 4-methyl-5H-2,3-benzodiazepine,
1-[3,4-bis(methyloxy)phenyl]-5-ethyl-4-methyl-7,8-bis(methyloxy)-5H-2,3-benzodiazepine,
(1Z,3Z)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-benzo[d][1,2]diazepine,
Dextofisopam,
UNII-UZC80HAU42,
Tofisopam [DCF:INN:JAN],
UZC80HAU42,
C22H26N2O4,
CID5502,
C22-H26-N2-O4,
CS-O-30804,
T3509,
TF,